Agilent Technologies Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
Agilent Technologies wird ein jährliches Gewinn- und Umsatzwachstum von 7.5% bzw. 5.1% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 8.5% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 24.8% betragen.
Wichtige Informationen
3.7%
Wachstumsrate der Gewinne
5.6%
EPS-Wachstumsrate
| Life Sciences Gewinnwachstum | 18.0% |
| Wachstumsrate der Einnahmen | 5.2% |
| Zukünftige Eigenkapitalrendite | 25.3% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 27 Aug 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
With EPS Growth And More, Agilent Technologies (NYSE:A) Makes An Interesting Case
Sep 23
Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues
Sep 09Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi
Aug 23A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)
Aug 14Agilent: Making A Move To Ignite Some Growth
Jul 25Agilent Technologies (NYSE:A) Has A Pretty Healthy Balance Sheet
Jul 15Is Agilent A Buy Before Earnings? Examining The Pros And Cons
May 23Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$154?
May 22Subdued Growth No Barrier To Agilent Technologies, Inc.'s (NYSE:A) Price
May 07These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well
Apr 05Agilent Technologies: Cash Flow Returns On Investments And Conventional All Point To A Hold
Mar 12Agilent Technologies Hit A Homerun
Dec 24Agilent: A Wide Moat Company Expected To Return To Growth In 2024 (Rating Upgrade)
Dec 08Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly
Dec 07Agilent Technologies: Looking Undervalued Heading Into Earnings
Nov 17Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)
Oct 26Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart
Sep 26Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)?
Sep 08Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly
Aug 21Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)
Jul 23Agilent Technologies - A Wealth Compounder 30% Below Its Highs
Jul 13Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today
Jul 10What Is Agilent Technologies, Inc.'s (NYSE:A) Share Price Doing?
May 28Agilent Technologies Stock: Starting To Look Appealing
May 25These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Safely
Apr 17Calculating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)
Apr 03Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today
Mar 21Agilent Technologies, Inc.'s (NYSE:A) CEO Compensation Is Looking A Bit Stretched At The Moment
Mar 09Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 10/31/2026 | 7,255 | 1,484 | 1,590 | 1,907 | 14 |
| 10/31/2025 | 6,805 | 1,364 | 1,458 | 1,773 | 18 |
| 10/31/2024 | 6,479 | 1,302 | 1,278 | 1,594 | 18 |
| 7/31/2024 | 6,497 | 1,413 | 1,417 | 1,786 | N/A |
| 4/30/2024 | 6,591 | 1,242 | 1,538 | 1,896 | N/A |
| 1/31/2024 | 6,735 | 1,236 | 1,649 | 1,961 | N/A |
| 10/31/2023 | 6,833 | 1,240 | 1,474 | 1,772 | N/A |
| 7/31/2023 | 6,994 | 1,133 | 1,420 | 1,704 | N/A |
| 4/30/2023 | 7,040 | 1,351 | 1,183 | 1,468 | N/A |
| 1/31/2023 | 6,930 | 1,323 | 1,061 | 1,353 | N/A |
| 10/31/2022 | 6,848 | 1,254 | 1,021 | 1,312 | N/A |
| 7/31/2022 | 6,659 | 1,328 | 1,022 | 1,305 | N/A |
| 4/30/2022 | 6,527 | 1,263 | 1,058 | 1,313 | N/A |
| 1/31/2022 | 6,445 | 1,205 | 1,280 | 1,502 | N/A |
| 10/31/2021 | 6,319 | 1,210 | 1,297 | 1,485 | N/A |
| 7/31/2021 | 6,142 | 990 | 1,268 | 1,421 | N/A |
| 4/30/2021 | 5,817 | 925 | 1,253 | 1,377 | N/A |
| 1/31/2021 | 5,530 | 810 | 1,092 | 1,218 | N/A |
| 10/31/2020 | 5,339 | 719 | 802 | 921 | N/A |
| 7/31/2020 | 5,223 | 691 | 736 | 858 | N/A |
| 4/30/2020 | 5,236 | 683 | 665 | 810 | N/A |
| 1/31/2020 | 5,236 | 764 | 598 | 749 | N/A |
| 10/31/2019 | 5,163 | 1,071 | 865 | 1,021 | N/A |
| 7/31/2019 | 5,090 | 1,072 | 917 | 1,079 | N/A |
| 4/30/2019 | 5,019 | 1,117 | 887 | 1,034 | N/A |
| 1/31/2019 | 4,987 | 1,140 | 929 | 1,085 | N/A |
| 10/31/2018 | 4,914 | 316 | 910 | 1,087 | N/A |
| 7/31/2018 | 4,809 | 298 | 804 | 1,003 | N/A |
| 4/30/2018 | 4,720 | 237 | N/A | 1,034 | N/A |
| 1/31/2018 | 4,616 | 196 | N/A | 988 | N/A |
| 10/31/2017 | 4,472 | 684 | N/A | 889 | N/A |
| 7/31/2017 | 4,394 | 633 | N/A | 835 | N/A |
| 4/30/2017 | 4,324 | 582 | N/A | 801 | N/A |
| 1/31/2017 | 4,241 | 509 | N/A | 798 | N/A |
| 10/31/2016 | 4,202 | 462 | N/A | 793 | N/A |
| 7/31/2016 | 4,126 | 476 | N/A | 800 | N/A |
| 4/30/2016 | 4,096 | 465 | N/A | 714 | N/A |
| 1/31/2016 | 4,040 | 466 | N/A | 643 | N/A |
| 10/31/2015 | 4,038 | 438 | N/A | 1,322 | N/A |
| 7/31/2015 | 4,046 | 306 | N/A | 1,245 | N/A |
| 4/30/2015 | 4,041 | 256 | N/A | 1,165 | N/A |
| 1/31/2015 | 4,066 | 204 | N/A | 1,307 | N/A |
| 10/31/2014 | 4,048 | 232 | N/A | 731 | N/A |
| 7/31/2014 | 4,723 | 435 | N/A | 924 | N/A |
| 4/30/2014 | 5,366 | 540 | N/A | 1,111 | N/A |
| 1/31/2014 | 6,110 | 666 | N/A | 1,101 | N/A |
| 10/31/2013 | 3,894 | 225 | N/A | 1,152 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: ADas prognostizierte Gewinnwachstum (7.5% pro Jahr) liegt über der Sparquote (2.4%).
Ertrag vs. Markt: ADie Erträge des Unternehmens (7.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.8% pro Jahr).
Hohe Wachstumserträge: ADie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: ADie Einnahmen des Unternehmens (5.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.7% pro Jahr).
Hohe Wachstumseinnahmen: ADie Einnahmen des Unternehmens (5.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: ADie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (24.8%)